Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Payables (2016 - 2025)

Cosmos Health's Payables history spans 13 years, with the latest figure at $16.8 million for Q4 2025.

  • Quarterly results put Payables at $16.8 million for Q4 2025, up 45.31% from a year ago — trailing twelve months through Dec 2025 was $16.8 million (up 45.31% YoY), and the annual figure for FY2025 was $16.8 million, up 45.31%.
  • Payables for Q4 2025 was $16.8 million at Cosmos Health, down from $17.8 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $26.8 million in Q3 2021 to a low of $675922.0 in Q1 2022.
  • The 5-year median for Payables is $12.5 million (2023), against an average of $13.5 million.
  • The sharpest move saw Payables plummeted 94.27% in 2022, then surged 1628.0% in 2023.
  • Year by year, Payables stood at $12.1 million in 2021, then increased by 24.95% to $15.2 million in 2022, then grew by 9.02% to $16.5 million in 2023, then plummeted by 30.17% to $11.5 million in 2024, then skyrocketed by 45.31% to $16.8 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $16.8 million, $17.8 million, and $18.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.